Unknown

Dataset Information

0

Proteomic Portraits Reveal Evolutionarily Conserved and Divergent Responses to Spinal Cord Injury.


ABSTRACT: Despite the emergence of promising therapeutic approaches in preclinical studies, the failure of large-scale clinical trials leaves clinicians without effective treatments for acute spinal cord injury (SCI). These trials are hindered by their reliance on detailed neurological examinations to establish outcomes, which inflate the time and resources required for completion. Moreover, therapeutic development takes place in animal models whose relevance to human injury remains unclear. Here, we address these challenges through targeted proteomic analyses of cerebrospinal fluid and serum samples from 111 patients with acute SCI and, in parallel, a large animal (porcine) model of SCI. We develop protein biomarkers of injury severity and recovery, including a prognostic model of neurological improvement at 6 months with an area under the receiver operating characteristic curve of 0.91, and validate these in an independent cohort. Through cross-species proteomic analyses, we dissect evolutionarily conserved and divergent aspects of the SCI response and establish the cerebrospinal fluid abundance of glial fibrillary acidic protein as a biochemical outcome measure in both humans and pigs. Our work opens up new avenues to catalyze translation by facilitating the evaluation of novel SCI therapies, while also providing a resource from which to direct future preclinical efforts.

SUBMITTER: Skinnider MA 

PROVIDER: S-EPMC8260874 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Proteomic Portraits Reveal Evolutionarily Conserved and Divergent Responses to Spinal Cord Injury.

Skinnider Michael A MA   Rogalski Jason J   Tigchelaar Seth S   Manouchehri Neda N   Prudova Anna A   Jackson Angela M AM   Nielsen Karina K   Jeong Jaihyun J   Chaudhary Shalini S   Shortt Katelyn K   Gallagher-Kurtzke Ylonna Y   So Kitty K   Fong Allan A   Gupta Rishab R   Okon Elena B EB   Rizzuto Michael A MA   Dong Kevin K   Streijger Femke F   Belanger Lise L   Ritchie Leanna L   Tsang Angela A   Christie Sean S   Mac-Thiong Jean-Marc JM   Bailey Christopher C   Ailon Tamir T   Charest-Morin Raphaele R   Dea Nicolas N   Wilson Jefferson R JR   Dhall Sanjay S   Paquette Scott S   Street John J   Fisher Charles G CG   Dvorak Marcel F MF   Shannon Casey C   Borchers Christoph C   Balshaw Robert R   Foster Leonard J LJ   Kwon Brian K BK  

Molecular & cellular proteomics : MCP 20210612


Despite the emergence of promising therapeutic approaches in preclinical studies, the failure of large-scale clinical trials leaves clinicians without effective treatments for acute spinal cord injury (SCI). These trials are hindered by their reliance on detailed neurological examinations to establish outcomes, which inflate the time and resources required for completion. Moreover, therapeutic development takes place in animal models whose relevance to human injury remains unclear. Here, we addr  ...[more]

Similar Datasets

| S-EPMC11759441 | biostudies-literature
| S-EPMC384792 | biostudies-literature
| S-EPMC2864575 | biostudies-literature
| S-EPMC7870583 | biostudies-literature
| S-EPMC3236632 | biostudies-literature
| S-EPMC6240315 | biostudies-literature
2020-06-09 | MSV000085567 | MassIVE
| S-EPMC8646091 | biostudies-literature
| S-EPMC4074295 | biostudies-literature
| S-EPMC4465862 | biostudies-literature